Coalescence Partners Investment Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
KraneShares CSI China Internet ETF
KWEB
|
+$37.2M |
| 2 |
Mastercard
MA
|
+$12.8M |
| 3 |
Roper Technologies
ROP
|
+$12.8M |
| 4 |
Equifax
EFX
|
+$7.79M |
| 5 |
Amazon
AMZN
|
+$4.21M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$4.48M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.31% |
| 2 | Financials | 27.15% |
| 3 | Consumer Discretionary | 8.53% |
| 4 | Industrials | 6.27% |
| 5 | Healthcare | 4.48% |
Similar funds
Coalescence Partners Investment Management's Q3 2024 Portfolio in Review
As of Q3 2024, Coalescence Partners Investment Management held 15 positions worth $223M, up 83% from $122M the previous quarter. Its ten largest holdings account for 83% of the portfolio.
Coalescence Partners Investment Management deployed $80.6M of net new capital in Q3 2024, opening 3 new positions and adding to 7 existing holdings. Its largest new stake was KraneShares CSI China Internet ETF: 1,382,948 shares worth $47M.
By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 40% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Thermo Fisher Scientific, an estimated $4.48M trimmed.
- Coalescence Partners Investment Management's largest Q3 2024 buy was KraneShares CSI China Internet ETF: 1,382,948 shares worth $47M.
- Coalescence Partners Investment Management added most to Equifax in Q3 2024, an estimated $7.79M increase.
- Coalescence Partners Investment Management's biggest Q3 2024 reduction was Thermo Fisher Scientific, cutting an estimated $4.48M.
- Coalescence Partners Investment Management's ten largest holdings make up 83% of its $223M portfolio in Q3 2024.
- Coalescence Partners Investment Management opened 3 new positions and closed 0 in Q3 2024.
- Coalescence Partners Investment Management's portfolio value rose 83% quarter-over-quarter to $223M.
Based on Coalescence Partners Investment Management's 13F filing for Q3 2024, filed 4 Nov 2024.